Debiopharm Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Lausanne Switzerland (1979)

Organization Overview

First Clinical Trial
2006
NCT00331188
First Marketed Drug
2000
triptorelin (Trelstar)
First NDA Approval
2000
triptorelin (Trelstar)
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Debiopharm International SA | Debiopharm International S.A. | Debiopharm International, S.A. | Debiopharm SA | Debiovision